Literature DB >> 30325284

Kinetic Imaging in Lower Extremity Arteriography: Comparison to Digital Subtraction Angiography.

Marcell Gyánó1, István Góg1, Viktor I Óriás1, Zoltán Ruzsa1, Balázs Nemes1, Csaba Csobay-Novák1, Zoltán Oláh1, Zsuzsa Nagy1, Béla Merkely1, Krisztián Szigeti1, Szabolcs Osváth1, Péter Sótonyi1.   

Abstract

Purpose To compare the image quality produced by kinetic imaging in x-ray angiography and the current reference standard digital subtraction angiography (DSA). Materials and Methods This prospective observational crossover study enrolled 42 patients undergoing lower limb x-ray angiography between February and June 2017 (mean age, 68.7 years; age range, 49-89 years; 32 men [mean age, 67.1 years; age range, 49-89 years] and 10 women [mean age, 75 years; age range, 57-85 years]). Signal-to-noise ratios (SNRs) of DSA and kinetic image pairs were compared. Visual quality comparisons were also performed by specialists who used an online questionnaire. Interrater agreement was characterized by percent agreement and Fleiss k. Results A total of 1902 regions of interest were carefully selected in 110 image pairs to calculate and compare the SNRs. Median SNR in raw kinetic images was 3.3-fold and 2.3-fold higher than raw and postprocessed DSA images, respectively. A total of 232 pairs of raw and postprocessed kinetic images were compared. It was indicated that postprocessing improved the quality of kinetic images in 63.9% (2668 of 4176) of the comparisons. Interrater agreement was 75% and Fleiss k was 0.12 (P < .001). Also, 238 pairs of kinetic and DSA images were compared. Kinetic imaging was judged to have provided higher quality images than DSA in 69.0% (2462 of 3570) of the comparisons. The interrater agreement was 81% and Fleiss k was 0.17 (P < .001). Conclusion Kinetic imaging helps to view the same structures as digital subtraction angiography but offers better image quality. The improved signal-to-noise ratio suggests that this approach could reduce radiation exposure and improve the ability to view smaller vessels. © RSNA, 2018 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2018        PMID: 30325284     DOI: 10.1148/radiol.2018172927

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Initial evidence of a 50% reduction of contrast media using digital variance angiography in endovascular carotid interventions.

Authors:  Viktor I Óriás; Dávid Szöllősi; Marcell Gyánó; Dániel S Veres; Sándor Nardai; Csaba Csobay-Novák; Balázs Nemes; János P Kiss; Krisztián Szigeti; Szabolcs Osváth; Péter Sótonyi; Zoltán Ruzsa
Journal:  Eur J Radiol Open       Date:  2020-11-17

2.  Digital Variance Angiography in Selective Lower Limb Interventions.

Authors:  Rohit P Thomas; Moritz B Bastian; Simon Viniol; Alexander M König; Sandeep S Amin; Osama Eldergash; Johannes Schnabel; Marcell Gyánó; Dávid Szöllősi; István Góg; János P Kiss; Szabolcs Osváth; Krisztián P Szigeti; Andreas H Mahnken
Journal:  J Vasc Interv Radiol       Date:  2021-10-13       Impact factor: 3.464

3.  Digital variance angiography allows about 70% decrease of DSA-related radiation exposure in lower limb X-ray angiography.

Authors:  Marcell Gyánó; Márton Berczeli; Csaba Csobay-Novák; Dávid Szöllősi; Viktor I Óriás; István Góg; János P Kiss; Dániel S Veres; Krisztián Szigeti; Szabolcs Osváth; Ákos Pataki; Viktória Juhász; Zoltán Oláh; Péter Sótonyi; Balázs Nemes
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

4.  Automatic localization of the prostatic urethra for image guided radiation therapy.

Authors:  Nicola J Nasser; Jonathan Klein; Eyal Fenig; Abed Agbarya
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2021-06-11

5.  Digital Variance Angiography in Lower-Limb Angiography with Metal Implants.

Authors:  M B Bastian; A M König; S Viniol; M Gyánó; D Szöllősi; I Góg; J P Kiss; S Osvath; K Szigeti; A H Mahnken; R P Thomas
Journal:  Cardiovasc Intervent Radiol       Date:  2020-11-03       Impact factor: 2.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.